BHCM
PYXS icon

Brevan Howard Capital Management’s Pyxis Oncology PYXS Stock Holding History

Brevan Howard Capital Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-35,987
Closed -$153K – 1341
2024
Q1 		$153K Buy
+35,987
New +$151K ﹤0.01% 842

Other funds holding PYXS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brevan Howard Capital Management's PYXS Position: Q2 2024 in Review

Brevan Howard Capital Management sold out of Pyxis Oncology (PYXS) in Q2 2024, closing a stake of 35,987 shares — an estimated $153K sold.

Brevan Howard Capital Management first reported a position in PYXS in Q1 2024 and held it in 1 quarter. The position peaked at $153K in Q1 2024. 80 funds tracked by Wall St. Rank hold PYXS as of Q2 2024.

  • Brevan Howard Capital Management reported no remaining Pyxis Oncology position as of Q2 2024 after selling out during the quarter.
  • Brevan Howard Capital Management sold 35,987 Pyxis Oncology shares in Q2 2024, an estimated $153K.
  • Brevan Howard Capital Management first reported a position in Pyxis Oncology in Q1 2024 and held it in 1 quarter.
  • Brevan Howard Capital Management's Pyxis Oncology position peaked at $153K in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2024.

Based on Brevan Howard Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.